Skip to main content
letter
. 2022 Jul 4;28(11):1520–1521. doi: 10.1016/j.cmi.2022.06.028

Table 1.

Respiratory support in all COVIDSTORM study patients

Tocilizumab Standard of care
None 9 16% 2 7%
Nasal flow 1–6 L/min 16 28% 8 28%
Venturi mask 28% 6 11% 5 17%
Venturi mask 40% 7 12% 4 14%
Venturi mask 60% 4 7% 5 17%
High flow >15 L/min 11 19% 4 14%
NIV 4 7% 0 0%
IMV 0 0% 1 3%
Total 57 29

IMV, Invasive mechanical ventilation; NIV, Non-invasive ventilation.